Article
Development and Clinical Utility of a Blood-Based Test Service for the Rapid Identification of Actionable Mutations in Non-Small Cell Lung Carcinoma.
The Journal of molecular diagnostics : JMD - 1 May 2017
Mellert Hestia, Foreman Trudi, Jackson Leisa, Maar Dianna, Thurston Scott, Koch Kristina, Weaver Amanda, Cooper Samantha, Dupuis Nicholas, Sathyanarayana Ubaradka G, Greer Jakkie, Hahn Westen, Shelton Dawne, Stonemetz Paula, Pestano Gary A
Abstract excerpt
Nearly 80% of cancer patients do not have genetic mutation results available at initial oncology consultation; up to 25% of patients begin treatment before receiving their results. These factors hinder the ability to pursue optimal treatment strategies. This study validates a blood-based genome-testing service that provides accurate results within 72 hours. We focused on targetable variants in advanced non-small...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.